Applied Biology, Inc.

This clinical trial is testing a topical treatment called DA-001 to see if it safely reduces hair shedding and helps hair grow back. The study will enroll 800 women aged 18 and older who have been diagnosed with telogen effluvium, a type of hair loss. Participants will apply the …

This study is testing a new topical gel called DA-020 to see if it can reduce hair loss caused by chemotherapy. It is for women with early-stage breast cancer who are about to start a specific type of chemo. The gel works by temporarily reducing blood flow to the scalp, which may…

This study is testing a topical medication called CS-002 to see if it can safely restore natural color to grey hair. It will involve 100 healthy adults aged 30-65 who have grey hair. The goal is to see if applying this cream can reduce the amount of grey hair a person has.

This early study aims to understand how much of an experimental scalp treatment called DA-020 gets into the bloodstream after one application. It will involve 60 healthy women to measure the drug's levels and check for safety issues like blood pressure changes. The goal is to gat…